During the past decade, MBCCOP - University of New Mexico HSC conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 27 clinical trials were completed, i.e. on average, 58.7% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 10 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MBCCOP - University of New Mexico HSC" #1 sponsor was "SWOG Cancer Research Network" with 53 trials, followed by "University of New Mexico" with 30 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "Mannkind Corporation" with 5 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MBCCOP - University of New Mexico HSC" #1 collaborator was "National Cancer Institute (NCI)" with 80 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "MBCCOP - University of New Mexico HSC" are "Lung Cancer" (12 trials), "Breast Cancer" (9 trials), "Leukemia" (8 trials), "Lymphoma" (7 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "MBCCOP - University of New Mexico HSC" in a lesser frequency.

Most popular intervention types in "MBCCOP - University of New Mexico HSC" are "Drug" (137 trials), "Biological" (23 trials), "Radiation" (19 trials), "Procedure" (18 trials) and "Other" (12 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (15 trials), "radiation therapy" (15 trials), "Placebo" (13 trials), "cyclophosphamide" (10 trials) and "fluorouracil" (10 trials). Other intervention names were less common.

The vast majority of trials in "MBCCOP - University of New Mexico HSC" are 145 trials for "All" genders, 27 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "MBCCOP - University of New Mexico HSC". undefined are not yet recruiting, 18 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 124 completed trials in MBCCOP - University of New Mexico HSC, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in MBCCOP - University of New Mexico HSC, 3 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 30 trials that are defined as “Not Applicable".